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 Fatigue contributes substantially to decrements of quality of life in Multiple Sclerosis (MS) yet, 
available treatments demonstrate limited efficacy. Transcranial direct current stimulation (tDCS) is a form of 
non-invasive brain stimulation which presents promise in the management of fatigue, likely related to its 
capacity to modulate fatigue-related changes in corticospinal excitability. However, high variability limits its 
clinical application. There is some evidence for capitalising on homeostatic metaplasticity using tDCS as a 
way to boost outcomes however, this remains to be explored in fatigue in MS. We investigated the impact of 
cathodal tDCS (ctDCS) priming on anodal tDCS (atDCS)-induced corticospinal excitability and fatigue 
modulation in MS. 10 MS patients and 10 healthy controls completed a fatiguing exercise whilst receiving 
either ctDCS or sham (stDCS) primed atDCS to the motor cortex. We assessed change in maximal voluntary 
contraction force and motor evoked potential (MEP) amplitude across time. Force similarly declined during 
fatiguing exercise irrespective of group (P ≥ 0.15) and neuromodulation (P ≥ 0.09). However, force returned 
to baseline in controls post-exercise with ctDCS-atDCS (P ≥ 0.14), highlighting a possible interaction between 
excitability modulation during, and recovery of force following exercise. In healthy controls, MEP facilitation 
brought about by stDCS primed atDCS (P < 0.01) and exercise alone (P < 0.01) was enhanced with ctDCS 
primed atDCS. This effect was absent in MS (P ≥ 0.13) suggesting an impairment of metaplasticity 
mechanisms. These findings expand understanding of tDCS effects in MS and emphasize important 




Multiple Sclerosis (MS) is an immune-mediated disease characterised by demyelination, 
inflammation, and neurodegeneration of the central nervous system1. MS patients characteristically exhibit 
elevated motor fatigue2-4; an abnormality which ultimately limits their ability to perform daily tasks and 
contributes to substantial decrements in quality of life. 
Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique involving 
the delivery, via electrodes, of low-intensity electrical current which can modulate corticospinal excitability in 
targeted motor regions5-7. Online tDCS effects are mainly related to a polarity-specific bidirectional 
modification of membrane resting potential5, 8, 9. Anodal tDCS (atDCS) increases excitability by causing 
subthreshold membrane depolarisation; whereas, cathodal tDCS (ctDCS) causes subthreshold 
hyperpolarisation and an excitability decrease7, 9, 10. Prolonged stimulation can induce lasting enhancement and 
diminution of synaptic efficacy5, compatible with the persistent forms of neuroplasticity known as long-term 
potentiation (LTP) and long-term depression (LTD), respectively10, 11.  
 It is well-documented that corticospinal excitability increases during single-joint fatiguing exercise, 
which is thought to reflect a boost in motor output to the muscle to compensate for the progressive difficulty 
in maintaining contractile force12, 13. Little is known about how tDCS interacts with motor fatigue in MS. 
However in healthy populations, tDCS delivered to the motor cortex has demonstrated efficacy, possibly by 
modulating fatigue related changes in corticospinal excitability14-16. Still, high variability and small sample 
sizes limit its clinical application. Inconsistency in tDCS effects can result from a multiplicity of intrinsic17-20 
and extrinsic variables7; hence, a number of questions remain as to how to apply tDCS in order to optimise its 
functional outcomes. Beyond the parameters of the stimulation itself, the direction and magnitude of effects 
critically depend on the level of synaptic activity at the time of stimulation, as well as the history of synaptic 
activity in the targeted region. All neural activity is subject to homeostatic regulation that ensures the stability 
of neural function21, 22. Accordingly, non-linear phenomena arise such that a stimulus which characteristically 
increases excitability can lead to decreased excitability if applied with another excitatory stimulus23-25.  
 Metaplasticity is a form of neural activity regulation in which the induction of synaptic change is 
dependent on the history of activity at the synapse. It functions to keep synaptic activity within a dynamic 
range to support  the integration of temporally spaced episodes of synaptic change26. The Bienenstock-Cooper-
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Munro model23 provides a theoretical solution to metaplasticity, proposing that the threshold for synaptic 
modification dynamically and bidirectionally adjusts as a function of prior activity. Specifically, prior LTD 
shifts the modification threshold to the left, making the induction of further LTD more difficult and LTP more 
likely. The opposite is observed with prior LTP23, 26, 27. Capitalising on metaplasticity, previous studies 
applying temporally separate periods of tDCS to the motor cortex have demonstrated efficacy for improving 
motor learning and skill acquisition in healthy individuals28, 29. Overall, lowering the modification threshold 
with ctDCS priming appears to be advantageous for boosting both functional and corticospinal excitability 
outcomes of subsequent atDCS28, 29. While understanding of how to best apply tDCS to exploit metaplasticity 
is incomplete, this data is encouraging. To date, the impact of metaplastic neuromodulation on motor fatigue 
has not been explored in MS.  
 The aim of this study was to investigate the interaction between metaplastic neuromodulation and 
fatigue in MS. We hypothesised that ctDCS primed atDCS applied concurrently with fatiguing exercise would 






11 MS patients (10 relapsing remitting and one primary progressive MS) from the MS Society of 
South Australia and 10 healthy control subjects (matched for age, gender, handedness (Edinburgh Handedness 
Inventory30), and physical activity (International Physical Activity Questionnaire31)) were recruited for 
participation in the study. Subjects were excluded for any contraindications to transcranial magnetic 
stimulation (TMS) such as metallic implants in the skull, cardiac pacemaker, pregnancy, and/or history of 
seizures/epilepsy. Patients using Selective Serotonin Reuptake Inhibitors (SSRI) (N = 3) were included in the 
study so that the sample would be representative of the population; anti-depressant use is frequent in MS32. 
Procedures were approved by the University of Adelaide Human Research Ethics Committee and conducted 




Experimental setup and electromyography 
Subjects were seated with the right elbow flexed approximately 90°, pronated forearm resting on a 
horizontal surface, and index finger abducted against a force transducer (MLP 100; Transducer Techniques, 
Temecula, USA). Forearm and wrist were restrained using a custom manipulandum (Fig. 1). Responses evoked 
from the right first dorsal interosseus (FDI) muscle were recorded using surface electromyography (EMG): 












Figure 1. Experimental setup.  
 
Experimental protocol 
All subjects completed three sessions, held in the afternoon to control for diurnal influence (at the 
same time of the day for each participant across sessions) and separated by at least 48 hours to avoid any 
intervention carryover effects5. Experimenter and subject were blind to tDCS polarities, which were pseudo-
randomised across sessions by a second experimenter.  
Before fatiguing exercise, maximal voluntary contraction (MVC) force was determined by calculating 
the average force across three 3-5-second maximal FDI abduction tasks. Baseline measurements of 
corticospinal excitability involved 15 single TMS pulses and 3 peripheral nerve stimulations (PNS). Subjects 
then received ctDCS or stDCS priming at rest. Measurements (15 TMS and 3 PNS) were taken at 2 minutes 
and 8 minutes post priming to detect priming effects on corticospinal excitability. Test stimulation (atDCS or 
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stDCS) commenced 10 minutes following the conclusion of priming. This inter-stimulation interval was 
appropriate for ensuring test stimulation was performed during after-effects of priming33.  Subjects were asked 
to describe any sensations from the tDCS at the beginning, middle, and end of all stimulation periods. 
Measurements (15 TMS and 3 PNS) were performed at 30 seconds following test stimulation commencement. 
Subjects then performed the fatiguing exercise involving 10 intermittent 30-second MVCs. Measurements (5 
TMS and 1 PNS) were taken between sets (~30 seconds). Subjects were verbally instructed to start and stop 
contracting. Visual feedback of force and EMG output was displayed on a computer screen (Fig. 1) and verbal 
encouragement to perform maximally was provided throughout the exercise. Immediately succeeding exercise, 
post-exercise measurements (15 TMS, 3 PNS and two 3-5-second MVCs with 30 seconds rest between 
contractions) were completed. Post-exercise measurements were repeated at 10 minutes and 20 minutes 


















Figure 2. Experimental protocol schematic. (A) baseline and priming tDCS (B) fatiguing exercise and test 
tDCS (C) recovery  
15 TMS + 3 PNS 5 TMS + 1 PNS 3-5 sec MVC 30 sec MVC 
Contraction 5% maximum EMG 
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Transcranial Direct Current Stimulation 
 Current was induced by two 35cm² saline-soaked, sponge electrodes and delivered using a battery-
powered direct current stimulator (NeuroConn DC Stimulator Plus, Germany). The active electrode was 
centred on the representational field of right FDI and reference electrode on the contralateral supraorbital 
region. This montage appears to be optimal for enhancing excitability of motor cortex7. All current was 
delivered at 1 mA intensity. atDCS and ctDCS were delivered for 15 minutes5, 7, 10. During stDCS, electrodes 
were positioned identically to real tDCS but stimulation was only delivered for 10 seconds (with 8-second 
ramp-up and ramp-down). This has demonstrated reliability as a sham protocol as subjects feel the initial 
sensations associated with real stimulation, but no corticospinal excitability changes are induced34. Three 
priming-test tDCS combinations were applied in separate sessions for all participants (i.e., stDCS-stDCS, 
stDCS-atDCS, and ctDCS-atDCS).  
 
Transcranial Magnetic Stimulation 
Measuring the amplitude of motor evoked potential (MEP), elicited by the delivery of single-pulse 
TMS, was used to evaluate corticospinal excitability. Stimuli were applied with a figure-of-eight coil (9cm 
external wing diameter) connected to a monophasic Magstim 200² magnetic stimulator (Magstim, Whitland, 
UK). The coil was held over the scalp at an angle of 45° to the sagittal plane, with the handle pointing laterally 
and posteriorly, to produce current flow in a posterior-anterior direction. All pulses were delivered to the 
representation of right FDI on left motor cortex while subjects contracted the muscle so it was active at 5% of 
maximum EMG (as established during baseline MVC trials). An active condition was preferred for practical 
ease; i.e., a lower stimulation intensity required to consistently produce MEP35. Hotspot was determined by 
mapping (at 50-60% of maximum stimulator output) for the region that corresponded to the largest amplitude 
MEP. Consistency of coil position was ensured by marking the tDCS electrodes and scalp with permanent 
marker and markings were continually checked throughout the protocol. The lowest stimulus intensity required 
to elicit a MEP distinguishable from background EMG signal in 3 of 5 trials, defined the active motor threshold 
(AMT). One primary progressive MS patient did not complete the experiment as their AMT exceeded 
maximum stimulator output and we were unable to obtain measurements. TMS intensity was set at 120% of 
AMT for all measurement blocks (MS: 63.3 ± 7.0%, CTRL: 62.7 ± 12.9% of maximum stimulator output)35. 
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Peripheral Nerve Stimulation 
Stimuli were delivered using a constant-current stimulator (DS7A; Digitimer, Hertfordshire, UK). A 
bipolar bar electrode probe was secured over the ulnar nerve at the wrist with cathode angled distally. The 
location was determined as the site which produced the largest compound muscle action potential (M-wave) 
in resting FDI at 10 mA of current. To establish the maximum M-wave (Mmax), stimulation intensity increased 
in increments of 5 mA until the amplitude of M-wave did not increase further. Test intensity was set at 120% 
of the intensity required to produce Mmax (MS: 26.6 ± 13.2 mA, CTRL: 22.4 ± 6.1 mA).  
 
Data Analysis 
MVC data were analysed manually using offline recordings on Spike2 software (Version 6.18). Peak 
force amplitude was measured during brief MVCs at baseline and post-exercise, and averaged across trials at 
each time point. Mean force (from initial peak to when subject was instructed to stop contracting) was 
measured for each of the 30-second MVCs throughout the exercise. Force data were expressed as a percentage 
of baseline force to account for baseline differences between groups. 
EMG was amplified with CED 1902 (1000x) and band-pass filtered (20Hz high pass, 1kHz low pass) 
before digitization with a 1401 interface (Cambridge Electronic Design, UK) at 2kHz and stored offline. The 
root mean squared EMG was measured for all MVCs. 
MEP and Mmax amplitudes were measured peak to peak in millivolts using offline recordings on 
Spike2 software. MEP trials were excluded from analysis if, within the 100 milliseconds prior to TMS pulse, 
voluntary EMG activity exceeded 0.1 millivolt in amplitude. MEP amplitude at individual time points were 
calculated as the average amplitude across all trials in the measurement block. MEPs were normalised to Mmax 
to reveal corticospinal changes and exclude changes at the level of the muscle. Values were expressed as a 
percentage of baseline.  
 
Statistical Analysis 
Statistical analyses were completed using IBM SPSS Statistics software (Version 24). Linear mixed 
model analyses with factors time, group (MS vs. CTRL), and neuromodulation (stDCS-stDCS vs. stDCS-
atDCS vs. ctDCS-atDCS), were used to determine main effects and interactions. For all comparisons, a 
Shapiro-Wilk test confirmed normality of the data. Specific significant differences were identified with 
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Bonferroni’s correction for multiple comparisons. Student t-tests (two-sampled, equal variance) were used for 
determining group differences in demographic characteristics at baseline. One-way analyses of variance were 
used for assessing differences between neuromodulation conditions in time of day, lab temperature, and 
humidity. All data in text and tables are expressed as mean ± SD and in figures as mean ± SEM. Significance 




tDCS was tolerated by all subjects. No adverse reactions were reported except for one subject who 
described mild headache during ctDCS. Subjects experienced comparable sensations during real and sham 
stimulation. The sensations described included tingling, itchiness, warmth, prickling, and burning. Majority 
reported sensations when asked at the beginning of stimulation but, felt nothing when asked in the middle and 
at the end of stimulation. There were no differences between neuromodulation conditions in time of day 




Characteristic MS (N = 10) CTRL (N = 10) 
Age (years) 49.0 ± 13.6 46.8 ± 16.4 
Sex (female) 6  6  
Height (cm) 169.2 ± 12.4 169.7 ± 12.0 
Weight (kg) 80.5 ± 15.7 72.2 ± 17.4 
Handedness 0.6 ± 0.5 0.5 ± 0.6 
Work index 2.5 ± 0.4 2.8 ± 0.8 
Sport index  2.1 ± 1.4 * 4.2 ± 1.3 
Leisure time index 2.5 ± 0.5 3.0 ± 0.8 
AMT 52.7 ± 4.1 52.3 ± 9.9 
SSRI use (N) 
EDSS 
3 
3.5 ± 2.4 
0 
FSS 5.7 ± 1.1  
mFIS 51.9 ± 10.9  
Disease duration (years) 7.1 ± 7.0  
Table 1. Demographic and clinical characteristics of patients and controls are summarised. Work, 
sport, and leisure time indices are sub-scales of International Physical Activity Questionnaire. Selective 
Serotonin Reuptake Inhibitor (SSRI). Expanded Disability Status Score (EDSS). Fatigue Severity Scale 
score (FSS). Modified Fatigue Impact Scale score (mFIS). *P < 0.05 compared to CTRL 
 
Corticospinal excitability  
There was a significant main effect of time (P < 0.01) on MEP amplitude normalised to Mmax, but 
not group (P = 0.89) nor neuromodulation (P = 0.48). There was a significant group x neuromodulation (P < 
0.01) and time x neuromodulation interaction (P = 0.04), but no significant group x time nor group x time x 
neuromodulation interactions (P ≥ 0.38).  
In stDCS-stDCS condition (Fig. 3A), throughout fatiguing exercise MEPs were facilitated compared 
to baseline (P ≤ 0.04). The pattern of MEP facilitation over time was similar between groups (P ≥ 0.40).  
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In stDCS-atDCS condition (Fig. 3B), slight MEP augmentation in MS and depression in CTRL was 
observed, compared to stDCS-stDCS. These changes were sufficient to produce significant group differences 
at time points fatigue 5, 7, 8, and 9 (P ≤ 0.04) but differences between stDCS-atDCS and stDCS-stDCS 
conditions did not reach significance (P ≥ 0.07), with the exception of a significant between condition 
difference at fatigue 5 in CTRL (P = 0.04).   
In ctDCS-atDCS condition (Fig. 3C), MEP significantly increased compared to stDCS-atDCS at 
fatigue 7, 8 and 9, and 0 min post-exercise in CTRL (P < 0.01). There was also significant MEP facilitation 
compared to stDCS-stDCS condition at fatigue 7 and 8, and 0 min post-exercise in CTRL (P ≤ 0.01). This 
effect was absent in MS (P ≥ 0.13). In both groups, MEP returned to baseline values by 10 minutes post-
exercise, across all neuromodulation conditions (P ≥ 0.07). ctDCS priming alone had no effect on MEP in 
either group, determined by no differences from baseline at 2 minutes and 8 minutes post priming (P ≥ 0.80). 
There were no main effects of time (P = 0.42), group (P = 0.66), or neuromodulation (P = 0.62), nor 




































































































































































































































































































































































































































































Figure 3. Mean MEP normalised to Mmax (% baseline) are displayed for both groups over time, across 
neuromodulation conditions (A) stDCS-stDCS, (B) stDCS-atDCS, (C) ctDCS-atDCS 
Purple columns represent MS; orange columns represent CTRL. Error bars indicate the mean ± SEM. 
Horizontal green line represents baseline at 100%.  
# indicates significant difference from baseline (P < 0.05).   
* indicates significant difference compared to CTRL (P < 0.05).  
$ indicates significant difference compared to stDCS-stDCS condition (P < 0.05). 
** indicates significant difference compared to stDCS-atDCS condition (P < 0.05). 
 
Fatigue 
There was a significant main effect of time on MVC force (% baseline) (P < 0.01) and an almost 
significant effect of group (P = 0.06) but, no significant effect of neuromodulation (P = 0.76) nor any 
significant interactions (P ≥ 0.09).  
During fatiguing exercise, MVC force progressively declined at a similar rate in both groups (P ≥ 
0.15), across all neuromodulation conditions (P ≥ 0.09) (Fig. 4). There was some evidence for recovery of 
MVC force in CTRL following the conclusion of fatiguing exercise in the ctDCS-atDCS condition, with no 
difference from baseline at 0 or 20 min post-exercise (P ≥ 0.14); whereas, it remained significantly attenuated 
in MS (P < 0.01) (Fig 4C). The group difference at 20 minutes post-exercise was significant (P = 0.01).  
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Figure 4. Fatigue results. MVC force (% baseline) is displayed for both groups over time, across 
neuromodulation conditions (A) stDCS-stDCS (B) stDCS-atDCS (C) ctDCS-atDCS.  
Purple columns represent MS; orange columns represent CTRL. Error bars indicate the mean ± SEM. 
Horizontal green line represents baseline at 100%.  
* indicates significant difference compared to CTRL (P < 0.05). 
# indicates significant difference from baseline (P < 0.05).  























































































































To the best of our knowledge, this study is the first to examine the interaction between metaplastic 
neuromodulation and fatigue in MS. Notably, it provides novel data on differential tDCS-induced modulation 
of MEP in patients compared to healthy subjects, likely related to an impairment of homeostatic mechanisms 
which normally intervene to prevent dysregulated corticospinal excitability. Specifically, neither ctDCS-
atDCS nor stDCS-atDCS were related to significant shifts in corticospinal excitability in MS patients, 
compared to the excitability facilitation induced by the exercise itself (stDCS-stDCS). Accordingly, no benefit 
was observed for fatigue during exercise. While we observed the expected enhancement of corticospinal 
excitability with ctDCS-atDCS in healthy subjects, this also did not translate to any effect for fatigue during 
exercise. Interestingly though, there looked to be a relationship between augmented excitability with ctDCS-
atDCS and the recovery of MVC force following fatiguing exercise. This highlights an interaction which may 
be worth exploring in future work.  
 
Effects of ctDCS and stDCS primed atDCS on corticospinal excitability 
The enhancement of MEP observed in healthy subjects with concurrent application of ctDCS primed 
atDCS and exercise, confirms our hypothesis and further substantiates the notion that induction of excitability 
change is sensitive to the state of the network imposed by the history of synaptic activity26, 27, 36, 37. This is in 
accordance with seminal metaplasticity studies which showed the efficacy of tDCS priming in shaping the 
magnitude, direction, and duration of effects36, 37. A novel finding of the present study is the absence of such 
an effect in MS patients, implying an impairment of metaplasticity mechanisms and fostering speculation about 
aligning pathophysiology. Since the exercise itself generated identically facilitated MEP in both groups, group 
distinctions in tDCS effects were in response to the neuromodulation.  
Our results do not illuminate which part of the complex excitability regulation machinery is implicated 
in MS however, the interference of gamma-Aminobutyric acid (GABA)-ergic inhibition is an attractive theory. 
In healthy motor cortex, tDCS-induced plasticity is dependent on changes at glutamatergic synapses, 
predominantly driven by N-methyl-D-aspartate receptor-dependent mechanisms9, 10. Though, GABAergic 
inhibition has also been shown to influence the direction and degree of effects38, 39. Pathological corticospinal 
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hyperexcitation is typically present in MS patients linked to elevated cerebral spinal fluid concentration of 
inflammatory cytokines, which are released during acute MS attacks40-42. Inflammatory cytokines have been 
shown to interfere with GABA-mediated inhibition and exacerbate glutamate-mediated excitation43. Since 
modulation of GABA-mediated inhibition and glutamate-mediated excitation are common to the mechanisms 
of both tDCS and the disease, the potential role of the associated synapses as a site for the failure of 
corticospinal excitability regulation in MS is highlighted. Even though no corticospinal excitability 
abnormalities were observed in patients at baseline, such abnormalities have typically been reported using 
different TMS measures of corticospinal excitability to those used in the present study, such as central motor 
conduction time and intracortical inhibition3, 40, 41, 44. Extensive investigation is required, involving the 
systematic manipulation of components of the metaplasticity machinery, in order to clarify this interpretation 
and determine the precise location of the fault.  
Trends for the alteration of corticospinal excitability were observed with stDCS-atDCS but these did 
not reach significance. It is interesting to note however, that the trend-wise alterations occurred in opposing 
directions between groups. That is, with stDCS-atDCS we observed enhancement in patients and diminution 
in controls, of exercise-induced MEP facilitation. Although it is broadly accepted that atDCS at rest induces 
MEP facilitation denoting LTP-like changes in synaptic efficacy5, 7, 9, 10, these changes are susceptible to 
reversal with behavioural engagement of the regions stimulated by the neuromodulation25, 45. For example, 
Thirugnasambandam et al.24 reported an abolishment of MEP changes with combined atDCS and voluntary 
muscle contraction. In the present study, the trend towards attenuation of exercise-induced MEP facilitation in 
control subjects, may reflect homeostatic mechanisms initiated to prevent hyperexcitation and ultimately 
preserve favourable neuronal function21, 22. The contrasting trend towards MEP amplification in MS patients 
harmonises with the proposition that excitability regulation mechanisms are defective in this clinical group.  
 
tDCS effects on fatigue 
 Force declined during exercise irrespective of group and neuromodulation. Since the shifts in 
corticospinal excitability were only slight in both groups with stDCS-atDCS, this may have been insufficient 
to counteract the progressive failure of the nervous system to drive the muscle maximally12. However, the 
significantly augmented excitability in healthy subjects with ctDCS-atDCS and lack of associated effect on 
force, obscures this interpretation. This implies that the development of fatigue during exercise may not rely 
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on corticospinal excitability changes. Abdelmoula et al.16 arrived at a similar conclusion in their study on 
healthy subjects but, observed the inverse relationship; i.e., atDCS improved fatigue without affecting 
corticospinal excitability. A key protocol distinction that could account for this contrasting result is the delivery 
of atDCS prior to commencement of exercise. Accordingly, it could be that force is resistant to online 
interventions and tDCS-induced fatigue amelioration might critically depend on the timing of stimulation. 
Contrariwise, Williams et al.14 applied atDCS during fatiguing exercise and reported improved performance. 
Mutually these experiments assessed fatigue by time to task failure in submaximal isometric contractions 
(rather than intermittent MVCs as in the present study). In view of this, it is possible that fatigue augmentation 
with tDCS is task specific and governed, at least in part, by exercise intensity. 
While significant alterations of excitability with ctDCS-atDCS did not influence force during exercise, 
there was evidence for a delayed benefit. Specifically, following the conclusion of fatiguing exercise, controls 
showed no difference in force from baseline at 0 or 20 min post-exercise; whereas in MS, force remained 
attenuated. This highlights a potential interaction between the modification of excitability during and the 
recovery of force following exercise but, further exploration with a larger sample is required to clarify this. An 
explanation for this result could be that the pronounced increase in excitability sufficiently facilitated motor 
output to compensate for the loss of contractile force accompanying fatigue12, 13. However, the temporal 
dissociation between MEP increase and force benefit complicates this interpretation. Delayed functional 
effects on motor learning have been demonstrated with a tDCS priming paradigm by Christova et al.28. In this 
experiment, ctDCS-atDCS facilitated learning retention as indicated by performance improvement at retest 
two weeks later. Current understanding of the mechanisms underlying such delayed effects are incomplete. 
Though, LTP involves a cascade of synaptic strengthening processes that are thought to continue after the 
conclusion of the LTP inducing stimulus11, 27. Conceivably, positive tDCS effects on force were related to the 
less immediate parts of the LTP process, accounting for the delay. Alternatively, tDCS may have indirectly 
influenced networks that contribute to force production beyond the motor cortex via functional connections. 
This may have generated changes in pathways that do not contribute to responses elicited via TMS. Probing 




Some limitations of the present study should be mentioned. First, it could be argued that metaplasticity 
was not generated in either group because the priming alone did not cause alteration of MEP. However, it has 
been demonstrated that subsequent synaptic modifications can occur even when priming stimulation does not 
cause detectable changes in excitability19, 26. Second, it is unclear whether effects with ctDCS-atDCS were 
explicitly related to the influence of ctDCS priming on MEP modulation by atDCS or on MEP modulation by 
the exercise itself. The inclusion of a ctDCS-stDCS condition would have resolved ambiguity around this 
interpretation. This provides an avenue for further investigation. Third, it is well known that innumerable 
variables can influence tDCS effects. Since hormones are potent regulators of plasticity19, we should ideally 
have controlled for fluctuations associated with menstrual cycle in female subjects. We also did not exclude 
patients taking SSRIs which can influence the magnitude and direction of tDCS effects; increased extracellular 
serotonin has been shown to magnify MEP facilitation with atDCS and cause excitation with ctDCS46. 
However, we believe a major confounding effect of serotonin is improbable as we did not observe such 
magnification of MEP facilitation with atDCS nor excitation with ctDCS in patients and theoretically, 
controlling for this neurotransmitter should only have strengthened findings. Disease phase is another 
noteworthy factor which should be taken into account in future investigations since the release of inflammatory 
cytokines during relapse influence GABAergic processes which participate in the mechanisms of tDCS. In 
view of this, and the inadequate statistical power due to small sample size, generalising our results to the 
broader clinical population must be carried out conservatively.  
 
Conclusions and significance 
This study provides novel data on differential tDCS modulation of corticospinal excitability in MS 
patients compared to healthy subjects, likely attributed to a failure of regulatory mechanisms which normally 
intervene to keep excitability within a functional range. In healthy subjects, we observed the expected 
augmentation of corticospinal excitability with ctDCS-atDCS, alongside the recovery of MVC force to 
baseline following the conclusion of exercise. Our data underline the state dependency of tDCS effects, i.e., 
the direction and extent of tDCS effects may be more precisely predicted by taking into account both the 
history of corticospinal excitability and the level of excitability at the time of stimulation, rather than solely 
parameters of the stimulation. The distinct responses to metaplastic neuromodulation between groups justifies 
the importance of exploring tDCS effects in MS, emphasising that predicting outcomes using studies on 
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healthy subjects is problematic. The data also suggest that an impairment of corticospinal excitability 
regulation mechanisms may be of crucial relevance in the pathophysiology of MS. Understanding of these 
factors has implications in the optimisation of tDCS protocols that aim to reduce fatigue and improve motor 






This work was supported by the 2020 Adelaide Medical School Honours Scholarship, the Faculty of Health 
and Medical Sciences Research Mentored Award and The University of Adelaide Women’s Research 





1. Lassmann H & Wekerle H (2006). Chapter 12 - The pathology of multiple sclerosis. In McAlpine's Multiple 
Sclerosis, 4th edn, ed. Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith 
K & Wekerle H, 557-599. Churchill Livingstone, Edinburgh.  
2. Sheean GL, Murray NM, Rothwell JC, Miller DH & Thompson AJ (1997). An electrophysiological study 
of the mechanism of fatigue in multiple sclerosis. Brain 120, 299-315. 
3. Petajan JH & White AT (2000). Motor-evoked potentials in response to fatiguing grip exercise in multiple 
sclerosis patients. Clin Neurophysiol 111, 2188-2195. 
4. Thickbroom G, Sacco P, Faulkner D, Kermode A & Mastaglia F (2008). Enhanced corticomotor excitability 
with dynamic fatiguing exercise of the lower limb in multiple sclerosis. J Neurol 255, 1001-1005. 
5. Nitsche MA & Paulus W (2001). Sustained excitability elevations induced by transcranial DC motor cortex 
stimulation in humans. Neurology 57, 1899-1901. 
6. Di Lazzaro V, Ranieri F, Profice P, Pilato F, Mazzone P, Capone F, Insola A & Oliviero A (2013). 
Transcranial direct current stimulation effects on the excitability of corticospinal axons of the human cerebral 
cortex. Brain Stimul 6, 641-3. 
7. Nitsche MA & Paulus W (2000). Excitability changes induced in the human motor cortex by weak 
transcranial direct current stimulation. J Physiol 527, 633-639. 
8. Fricke K, Seeber AA, Thirugnanasambandam N, Paulus W, Nitsche MA & Rothwell JC (2011). Time course 
of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the 
human motor cortex. J Neurophysiol 105, 1141-1149. 
9. Liebetanz D, Nitsche MA, Tergau F & Paulus W (2002). Pharmacological approach to the mechanisms of 
transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 125, 2238-47. 
10. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F & Paulus 
W (2003). Pharmacological Modulation of Cortical Excitability Shifts Induced by Transcranial Direct Current 
Stimulation in Humans. J Physiol 553, 293-301. 
11. Bliss TVP & Lømo T (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the 
anaesthetized rabbit following stimulation of the perforant path. J Physiol 232, 331-356. 
 24 
12. Taylor JL, Butler JE, Allen GM & Gandevia SC (1996). Changes in motor cortical excitability during 
human muscle fatigue. J Physiol 490 519-528. 
13. Gandevia SC, Allen GM, Butler JE & Taylor JL (1996). Supraspinal factors in human muscle fatigue: 
evidence for suboptimal output from the motor cortex. J Physiol 490 529-536. 
14. Williams PS, Hoffman RL & Clark BC (2013). Preliminary evidence that anodal transcranial direct current 
stimulation enhances time to task failure of a sustained submaximal contraction. PLoS One 8, 1-11. 
15. Cogiamanian F, Marceglia S, Ardolino G, Barbieri S & Priori A (2007). Improved isometric force 
endurance after transcranial direct current stimulation over the human motor cortical areas. Eur J Neurosci 26, 
242-249. 
16. Abdelmoula A, Baudry S & Duchateau J (2016). Anodal transcranial direct current stimulation enhances 
time to task failure of a submaximal contraction of elbow flexors without changing corticospinal excitability. 
Neurosci 322, 94-103. 
17. Thomas C, Ghodratitoostani I, Delbem ACB, Ali A & Datta A (2019). Influence of gender-related 
differences in transcranial direct current stimulation: A Computational Study. Conf Proc IEEE Eng Med Biol 
Soc 2019, 5196-5199. 
18. Datta A (2012). Inter-individual variation during transcranial direct current stimulation and normalization 
of dose using MRI-derived computational models. Frontiers in psychiatry 3, 1-8. 
19. Abraham WC (2008). Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci 9, 
387-399. 
20. Antal A, Chaieb L, Moliadze V, Monte-Silva K, Poreisz C, Thirugnanasambandam N, Nitsche MA, 
Shoukier M, Ludwig H & Paulus W (2010). Brain-derived neurotrophic factor (BDNF) gene polymorphisms 
shape cortical plasticity in humans. Brain Stimul 3, 230-237. 
21. Davis GW & Bezprozvanny I (2001). Maintaining the stability of neural function: a homeostatic 
hypothesis. Annu Rev Physiol 63, 847-869. 
22. Turrigiano GG & Nelson SB (2004). Homeostatic plasticity in the developing nervous system. Nat Rev 
Neurosci 5, 97-107. 
23. Bienenstock EL, Cooper LN & Munro PW (1982). Theory for the development of neuron selectivity: 
Orientation specificity and binocular interaction in visual cortex. J Neurosci 2, 32-48. 
 25 
24. Thirugnanasambandam N, Sparing R, Dafotakis M, Meister IG, Paulus W, Nitsche MA & Fink GR (2011). 
Isometric contraction interferes with transcranial direct current stimulation (tDCS) induced plasticity: evidence 
of state-dependent neuromodulation in human motor cortex. Restor Neurol Neurosci 29, 311-320. 
25. Huang YZ, Rothwell JC, Edwards MJ & Chen RS (2008). Effect of physiological activity on an NMDA-
dependent form of cortical plasticity in human. Cereb Cortex 18, 563-570. 
26. Abraham WC & Bear MF (1996). Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19, 
126-130. 
27. Abraham WC & Tate WP (1997). Metaplasticity: a new vista across the field of synaptic plasticity. Prog 
Neurobiol 52, 303-323. 
28. Christova M, Rafolt D & Gallasch E (2015). Cumulative effects of anodal and priming cathodal tDCS on 
pegboard test performance and motor cortical excitability. Behav Brain Res 287, 27-33. 
29. Fujiyama H, Hinder MR, Barzideh A, Van de Vijver C, Badache AC, Manrique-C MN, Reissig P, Zhang 
X, Levin O, Summers JJ & Swinnen SP (2017). Preconditioning tDCS facilitates subsequent tDCS effect on 
skill acquisition in older adults. Neurobiol Aging 51, 31-42. 
30. Oldfield RC (1971). The assessment and analysis of handedness: the Edinburgh inventory. 
Neuropsychologia 9, 97-113. 
31. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve 
A & Sallis JF (2003). International physical activity questionnaire: 12-country reliability and validity. Med Sci 
Sports Exerc 35, 1381-1395. 
32. Cetin K, Johnson KL, Ehde DM, Kuehn CM, Amtmann D & Kraft GH (2007). Antidepressant use in 
multiple sclerosis: epidemiologic study of a large community sample. Mult Scler 13, 1046-1053. 
33. Monte-Silva K, Kuo M-F, Liebetanz D, Paulus W & Nitsche MA (2010). Shaping the Optimal Repetition 
Interval for Cathodal Transcranial Direct Current Stimulation (tDCS). J Neurophysiol 103, 1735-1740. 
34. Ambrus GG, Al-Moyed H, Chaieb L, Sarp L, Antal A & Paulus W (2012). The fade-in–short stimulation–
fade out approach to sham tDCS–reliable at 1 mA for naive and experienced subjects, but not investigators. 
Brain Stimul 5, 499-504. 
35. Ngomo S, Leonard G, Moffet H & Mercier C (2012). Comparison of transcranial magnetic stimulation 
measures obtained at rest and under active conditions and their reliability. J Neurosci Methods 205, 65-71. 
 26 
36. Siebner HR, Lang N, Rizzo V, Nitsche MA, Paulus W, Lemon RN & Rothwell JC (2004). Preconditioning 
of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: 
evidence for homeostatic plasticity in the human motor cortex. J Neurosci 24, 3379-3385. 
37. Lang N, Siebner HR, Ernst D, Nitsche MA, Paulus W, Lemon RN & Rothwell JC (2004). Preconditioning 
with transcranial direct current stimulation sensitizes the motor cortex to rapid-rate transcranial magnetic 
stimulation and controls the direction of after-effects. Biol Psychiatry 56, 634-639. 
38. Stagg C, Bachtiar V & Johansen-Berg H (2011). The Role of GABA in Human Motor Learning. Curr Biol 
21, 480-484. 
39. Nitsche MA, Liebetanz D, Schlitterlau A, Henschke U, Fricke K, Frommann K, Lang N, Henning S, Paulus 
W & Tergau F (2004). GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in 
humans. Eur J Neurosci 19, 2720-2726. 
40. Britton T, Meyer B-U & Benecke R (1991). Variability of cortically evoked motor responses in multiple 
sclerosis. Electroencephalogr Clin Neurophysiol 81, 186-194. 
41. Liepert J, Mingers D, Heesen C, Bäumer T & Weiller C (2005). Motor cortex excitability and fatigue in 
multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler 11, 316-321. 
42. Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P, Martinelli V & Comi G 
(2001). Fatigue in Multiple Sclerosis Is Associated with Abnormal Cortical Activation to Voluntary 
Movement—EEG Evidence. Neuroimage 13, 1186-1192. 
43. Caramia MD, Palmieri MG, Desiato MT, Boffa L, Galizia P, Rossini PM, Centonze D & Bernardi G 
(2004). Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with 
transcranial magnetic stimulation. Clin Neurophysiol 115, 956-965. 
44. Hess CW, Mills KR, Murray NM & Schriefer TN (1987). Magnetic brain stimulation: central motor 
conduction studies in multiple sclerosis. Ann Neurol 22, 744-752. 
45. Staubli U & Chun D (1996). Factors regulating the reversibility of long-term potentiation. J Neurosci 16, 
853-860. 
46. Nitsche MA, Kuo MF, Karrasch R, Wachter B, Liebetanz D & Paulus W (2009). Serotonin affects 
transcranial direct current-induced neuroplasticity in humans. Biol Psychiatry 66, 503-508. 
 
